Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: We describe the utilization of telemedicine visits (video or telephone) across the type 1 diabetes (T1D) Exchange Quality Improvement Collaborative (T1DX-QI) during the COVID-19 pandemic. Metrics, site-level survey results, and examples of interventions conducted to support telemedicine in T1D are shown. Materials and Methods: Thirteen clinics (11 pediatric, 2 adult) provided monthly telemedicine metrics between December 2019 and August 2020 and 21 clinics completed a survey about their telemedicine practices. Results: The proportion of telemedicine visits in T1DX-QI before the pandemic was <1%, rising to an average of 95.2% in April 2020 (range 52.3%–99.5%). Three sites initially used mostly telephone visits before converting to video visits. By August 2020, the proportion of telemedicine visits decreased to an average of 45% across T1DX-QI (range 10%–86.6%). The majority of clinics (62%) performed both video and telephone visits; Zoom was the most popular video platform used. Over 95% of clinics reported using CareLink™, Clarity ® , Glooko™, and/or t:connect ® to view device data, with only one center reporting automated data upload into the electronic medical record. The majority of centers had multidisciplinary teams participating in the video visits. All sites reported reimbursement for video visits, and 95% of sites reported coverage for telephone visits early on in the pandemic. Conclusions: There was rapid adoption of telemedicine in T1DX-QI during the COVID-19 pandemic. Future insurance reimbursement for telemedicine visits and the ideal ratio of telemedicine to in-person visits in T1D care remain to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluating barriers to adopting telemedicine worldwide: A systematic review
Scott Kruse, C., Karem, P., Shifflett, K., Vegi, L., Ravi, K., & Brooks, M. (2018) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x16674087 · Cited by 1,735
Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.150885 · Cited by 281
Gilbert, A. W., Billany, J. C. T., Adam, R., Martin, L., Tobin, R., Bagdai, S., Galvin, N., Farr, I., Allain, A., Davies, L., et al. (2020) · BMJ Open Quality · doi:10.1136/bmjoq-2020-000985 · Cited by 251
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetologia · doi:10.1007/s00125-019-05034-1 · Cited by 125
Telemedicine consultation for patients with diabetes mellitus: A cluster randomised controlled trial
Sood, A., Watts, S. A., Johnson, J. K., Hirth, S., & Aron, D. C. (2018) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x17704346 · Cited by 86
Wu, C., Wu, Z., Yang, L., Zhu, W., Zhang, M., Zhu, Q., Chen, X., & Pan, Y. (2018) · Medicine · doi:10.1097/md.0000000000012962 · Cited by 86
Ruiz de Adana, M. S., Alhambra-Expósito, M. R., Muñoz-Garach, A., Gonzalez-Molero, I., Colomo, N., Torres-Barea, I., Aguilar-Diosdado, M., Carral, F., Serrano, M., Martínez-Brocca, M. A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0739 · Cited by 53
Cited by
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes
Wadwa, R. P., Reed, Z. W., Buckingham, B. A., DeBoer, M. D., Ekhlaspour, L., Forlenza, G. P., Schoelwer, M., Lum, J., Kollman, C., Beck, R. W., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2210834 · Cited by 191
Ebekozien, O., Fantasia, K., Farrokhi, F., Sabharwal, A., & Kerr, D. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15470 · Cited by 70
“28,29 Future studies of tele-health should ensure adequate representation of communities previously underrepresented.”
BackgroundSelf-citationAleppo, G., DeSalvo, D. J., Lauand, F., Huyett, L. M., Chang, A., Vienneau, T., & Ly, T. T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01366-9 · Cited by 19
Self-citation
Metadata
- Authors
- Lee, J. M., Carlson, E., Albanese-O'Neill, A., Demeterco-Berggren, C., Corathers, S. D., Vendrame, F., Weinstock, R. S., Prahalad, P., Alonso, G. T., Kamboj, M., DeSalvo, D. J., Malik, F. S., Izquierdo, R., & Ebekozien, O.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2021-09-01
- Volume
- 23
- Issue
- 9
- Pages
- 642-651
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W3155237711
- Cited by
- 77
- References
- 7
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic. https://app.cochat.ai/papers/10.1089/dia.2021.0080
- The paper
- Lee, J. M., Carlson, E., Albanese-O'Neill, A., Demeterco-Berggren, C., Corathers, S. D., Vendrame, F., Weinstock, R. S., Prahalad, P., Alonso, G. T., Kamboj, M., DeSalvo, D. J., Malik, F. S., Izquierdo, R., & Ebekozien, O. (2021). Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2021.0080
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.